Evidence map›Paper›PMID 37183774›Full record

ArticleInternational health2024

Successful completion of onchocerciasis elimination mapping (OEM) in Niger, West Africa.

Salissou Adamou, Daniel Boakye, Laouali Bouckari, Anne Heggen, Jamie Tallant, Yayé Youssouf, Charles D Mackenzie

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Salissou AdamouNiger Programme Onchocercose et Filariose Lymphatique, Niamey, Niger.
Daniel BoakyeReaching the Last Mile Fund, The END Fund, New York, NY 10016, USA.
Laouali BouckariNiger Programme Onchocercose et Filariose Lymphatique, Niamey, Niger.
Anne HeggenReaching the Last Mile Fund, The END Fund, New York, NY 10016, USA.
Jamie TallantReaching the Last Mile Fund, The END Fund, New York, NY 10016, USA.
Yayé YoussoufHeller Keller International, Niamey, Niger.
Charles D MackenzieReaching the Last Mile Fund, The END Fund, New York, NY 10016, USA.ORCID 0000-0003-4628-8188
Noguchi Memorial Institute for Medical Research · GHThe Task Force for Global Health · USUnited Nations Children's Fund Niger · NE

Funding

Bill and Melinda Gates Foundation OPP1193778
6 · The paper itself

Abstract

backgroundBy 1987, onchocerciasis in Niger had been successfully controlled in the six endemic river basins. In 2017, onchocerciasis elimination mapping (OEM) was carried out to determine if there was any ongoing transmission in the country as a whole.

methodsThe recommended OEM procedures were implemented.

resultsTen districts, that included 35 villages, required field investigation as sites of possible transmission. None of these were found capable of supporting black fly breeding, nor was there any evidence of the presence of Simulium sp. flies.

conclusionsThe implementation of OEM indicates that there is no transmission of onchocerciasis currently taking place in these newly assessed sites in Niger.

Indexed as

OnchocerciasisSimuliidaeAfrica, WesternAnimalsHumansIvermectinNigerIvermectinelimination mappingexclusion mappingNigeronchocerciasis

Identifiers

PMID37183774
PMCPMC10911525
OpenAlexW4376630559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.